vs
RHYTHM PHARMACEUTICALS, INC.（RYTM）与WESTAMERICA BANCORPORATION（WABC）财务数据对比。点击上方公司名可切换其他公司
WESTAMERICA BANCORPORATION的季度营收约是RHYTHM PHARMACEUTICALS, INC.的1.1倍（$63.3M vs $60.1M），WESTAMERICA BANCORPORATION净利率更高（43.9% vs -92.6%，领先136.5%），RHYTHM PHARMACEUTICALS, INC.同比增速更快（83.8% vs -9.0%），过去两年RHYTHM PHARMACEUTICALS, INC.的营收复合增速更高（43.8% vs -8.6%）
Rhythm Pharmaceuticals是一家专注于罕见病领域的生物制药企业，主要开发和商业化针对罕见遗传性肥胖症的靶向疗法，覆盖POMC缺陷、LEPR缺陷、巴德-毕德氏综合征等适应症，服务北美、欧洲地区缺少有效治疗方案的患者群体。
西美银行控股公司是总部位于美国加利福尼亚州的区域性银行控股集团，通过旗下全资银行子公司提供全品类零售及商业银行业务，涵盖存款产品、个人与企业贷款、财富管理、支付服务等，主要服务加州中北部的个人消费者、中小企业及本地机构客户。
RYTM vs WABC — 直观对比
营收规模更大
WABC
是对方的1.1倍
$60.1M
营收增速更快
RYTM
高出92.8%
-9.0%
净利率更高
WABC
高出136.5%
-92.6%
两年增速更快
RYTM
近两年复合增速
-8.6%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $60.1M | $63.3M |
| 净利润 | $-55.6M | $27.8M |
| 毛利率 | 88.1% | — |
| 营业利润率 | -87.1% | 59.8% |
| 净利率 | -92.6% | 43.9% |
| 营收同比 | 83.8% | -9.0% |
| 净利润同比 | — | -12.3% |
| 每股收益（稀释后） | $-0.83 | $1.12 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收RYTMWABC
| Q1 26 | $60.1M | — | ||
| Q4 25 | $57.3M | $63.3M | ||
| Q3 25 | $51.3M | $63.7M | ||
| Q2 25 | $48.5M | $64.6M | ||
| Q1 25 | $32.7M | $66.4M | ||
| Q4 24 | $41.8M | $69.6M | ||
| Q3 24 | $33.3M | $74.1M | ||
| Q2 24 | $29.1M | $74.3M |
净利润RYTMWABC
| Q1 26 | $-55.6M | — | ||
| Q4 25 | $-47.5M | $27.8M | ||
| Q3 25 | $-52.9M | $28.3M | ||
| Q2 25 | $-46.6M | $29.1M | ||
| Q1 25 | $-49.5M | $31.0M | ||
| Q4 24 | $-43.3M | $31.7M | ||
| Q3 24 | $-43.6M | $35.1M | ||
| Q2 24 | $-32.3M | $35.5M |
毛利率RYTMWABC
| Q1 26 | 88.1% | — | ||
| Q4 25 | 91.6% | — | ||
| Q3 25 | 89.3% | — | ||
| Q2 25 | 88.6% | — | ||
| Q1 25 | 88.8% | — | ||
| Q4 24 | 90.9% | — | ||
| Q3 24 | 88.5% | — | ||
| Q2 24 | 89.9% | — |
营业利润率RYTMWABC
| Q1 26 | -87.1% | — | ||
| Q4 25 | -82.2% | 59.8% | ||
| Q3 25 | -102.6% | 59.5% | ||
| Q2 25 | -93.4% | 60.5% | ||
| Q1 25 | -143.7% | 63.0% | ||
| Q4 24 | -98.6% | 62.8% | ||
| Q3 24 | -132.0% | 64.5% | ||
| Q2 24 | -139.2% | 64.8% |
净利率RYTMWABC
| Q1 26 | -92.6% | — | ||
| Q4 25 | -83.0% | 43.9% | ||
| Q3 25 | -103.1% | 44.3% | ||
| Q2 25 | -96.1% | 45.0% | ||
| Q1 25 | -151.4% | 46.7% | ||
| Q4 24 | -103.6% | 45.6% | ||
| Q3 24 | -131.2% | 47.3% | ||
| Q2 24 | -110.9% | 47.8% |
每股收益（稀释后）RYTMWABC
| Q1 26 | $-0.83 | — | ||
| Q4 25 | $-0.73 | $1.12 | ||
| Q3 25 | $-0.82 | $1.12 | ||
| Q2 25 | $-0.75 | $1.12 | ||
| Q1 25 | $-0.81 | $1.16 | ||
| Q4 24 | $-0.71 | $1.19 | ||
| Q3 24 | $-0.73 | $1.31 | ||
| Q2 24 | $-0.55 | $1.33 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $340.6M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $122.9M | $933.5M |
| 总资产 | $442.3M | $6.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资RYTMWABC
| Q1 26 | $340.6M | — | ||
| Q4 25 | $388.9M | — | ||
| Q3 25 | $416.1M | — | ||
| Q2 25 | $291.0M | — | ||
| Q1 25 | $314.5M | — | ||
| Q4 24 | $320.6M | — | ||
| Q3 24 | $298.4M | — | ||
| Q2 24 | $319.1M | — |
股东权益RYTMWABC
| Q1 26 | $122.9M | — | ||
| Q4 25 | $139.1M | $933.5M | ||
| Q3 25 | $148.8M | $931.6M | ||
| Q2 25 | $-11.9M | $921.8M | ||
| Q1 25 | $18.9M | $923.1M | ||
| Q4 24 | $21.7M | $890.0M | ||
| Q3 24 | $11.2M | $909.0M | ||
| Q2 24 | $39.3M | $815.6M |
总资产RYTMWABC
| Q1 26 | $442.3M | — | ||
| Q4 25 | $480.2M | $6.0B | ||
| Q3 25 | $506.9M | $5.9B | ||
| Q2 25 | $372.7M | $5.8B | ||
| Q1 25 | $386.7M | $6.0B | ||
| Q4 24 | $392.3M | $6.1B | ||
| Q3 24 | $363.6M | $6.2B | ||
| Q2 24 | $381.8M | $6.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $121.9M |
| 自由现金流经营现金流 - 资本支出 | — | $119.7M |
| 自由现金流率自由现金流/营收 | — | 189.0% |
| 资本支出强度资本支出/营收 | — | 3.5% |
| 现金转化率经营现金流/净利润 | — | 4.38× |
| 过去12个月自由现金流最近4个季度 | — | $213.4M |
8季度趋势，按日历期对齐
经营现金流RYTMWABC
| Q1 26 | — | — | ||
| Q4 25 | $-25.4M | $121.9M | ||
| Q3 25 | $-26.6M | $29.4M | ||
| Q2 25 | $-23.3M | $23.5M | ||
| Q1 25 | $-40.4M | $42.4M | ||
| Q4 24 | $-18.8M | $141.6M | ||
| Q3 24 | $-25.2M | $40.6M | ||
| Q2 24 | $-29.1M | $19.0M |
自由现金流RYTMWABC
| Q1 26 | — | — | ||
| Q4 25 | — | $119.7M | ||
| Q3 25 | — | $28.7M | ||
| Q2 25 | — | $22.8M | ||
| Q1 25 | — | $42.2M | ||
| Q4 24 | — | $139.8M | ||
| Q3 24 | — | $40.1M | ||
| Q2 24 | — | $18.6M |
自由现金流率RYTMWABC
| Q1 26 | — | — | ||
| Q4 25 | — | 189.0% | ||
| Q3 25 | — | 45.1% | ||
| Q2 25 | — | 35.3% | ||
| Q1 25 | — | 63.5% | ||
| Q4 24 | — | 201.0% | ||
| Q3 24 | — | 54.1% | ||
| Q2 24 | — | 25.0% |
资本支出强度RYTMWABC
| Q1 26 | — | — | ||
| Q4 25 | — | 3.5% | ||
| Q3 25 | — | 1.1% | ||
| Q2 25 | — | 1.1% | ||
| Q1 25 | — | 0.3% | ||
| Q4 24 | — | 2.5% | ||
| Q3 24 | — | 0.7% | ||
| Q2 24 | — | 0.6% |
现金转化率RYTMWABC
| Q1 26 | — | — | ||
| Q4 25 | — | 4.38× | ||
| Q3 25 | — | 1.04× | ||
| Q2 25 | — | 0.81× | ||
| Q1 25 | — | 1.37× | ||
| Q4 24 | — | 4.47× | ||
| Q3 24 | — | 1.16× | ||
| Q2 24 | — | 0.54× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
